Articles related to BIOMARKERS

Discover how Labcorp’s new ATN Profile can revolutionize your approach to diagnosing Alzheimer’s disease.

Don’t miss this crucial update on how biomarker-guided first-line treatment can substantially improve survival rates in advanced NSCLC patients.

Discover how MPO testing can offer a more comprehensive understanding of your patients’ health risks, including mortality beyond cardiovascular disease.

Discover how retinal assessments could offer a new diagnostic and treatment frontier in Parkinson’s disease, as recent findings demonstrate significant retinal degeneration correlated with disease progression.

Discover how finger-tapping patterns could aid early Alzheimer’s diagnosis, offering a cost-effective and less intrusive screening method.

Discover the implications of a newly identified depression subtype, “cognitive biotype,” which not only presents with significant cognitive impairments but also shows resistance to standard antidepressant treatments.